Los nuevos antivirales para la covid ofrecen esperanza frente a la variante ómicron
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Merck and Pfizer will soon debut prescription pills to treat Covid-19. And more drugs are on the way.
Merck and Pfizer will soon debut prescription pills to treat Covid-19. And more drugs are on the way.
The US federal government has ordered another 1.4 million doses of Merck & Co and Ridgeback Biotherapeutics’ oral antiviral molnupiravir for COVID-19, adding to an […]
The authorization of Merck’s easy-to-use Covid treatment, molnupiravir, is a step toward taming the pandemic.
The authorization of Merck’s easy-to-use Covid treatment, molnupiravir, is a step toward taming the pandemic.
The authorization of Merck’s easy-to-use Covid treatment, molnupiravir, is a step toward taming the pandemic.
The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.
The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.
As expected, Merck & Co has moved ahead swiftly with an emergency use application for its oral antiviral molnupiravir, aiming to protect people with mild […]
The drug maker will seek authorization for molnupiravir, the first drug of its kind for Covid. Experts said such pills could be a powerful tool […]
Copyright © 2024 | WordPress Theme by MH Themes